Raloxifene Hydrochloride

CHEMBL1116 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

510.0 g/mol

LogP

—

Phase

4

The hydrochloride salt form of raloxifene prescribed to strengthen bones and reduce fracture risk in postmenopausal women, as well as to lower the risk of certain breast cancers. It offers the bone-protective benefits of estrogen while acting as an estrogen blocker in breast tissue.

分子量

510.0000 g/mol

TPSA

98.20 Å²

治療領域

Endometriosis Benign Prostatic Hyperplasia Rheumatoid Arthritis Osteoporosis Schizophrenia Breast Cancer Cardiovascular Disease Prostate Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

Cl.O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12

InChI

InChI=1S/C28H27NO4S.ClH/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29;/h4-13,18,30-31H,1-3,14-17H2;1H

Molecular Formula

C28H28ClNO4S

HBD / HBA

3 / 6

回転可能結合数

7

重原子数

35

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

The hydrochloride salt form of raloxifene prescribed to strengthen bones and reduce fracture risk in postmenopausal women, as well as to lower the risk of certain breast cancers. It offers the bone-protective benefits of estrogen while acting as an estrogen blocker in breast tissue.

Yes, Raloxifene Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1116. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 54900. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Raloxifene Hydrochloride PillFYIで

構造

クイックデータ

分子式: C28H28ClNO4S
同義語: 1

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.